259 related articles for article (PubMed ID: 28683325)
1. Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer's Mouse Phenotypes.
Haas LT; Salazar SV; Smith LM; Zhao HR; Cox TO; Herber CS; Degnan AP; Balakrishnan A; Macor JE; Albright CF; Strittmatter SM
Cell Rep; 2017 Jul; 20(1):76-88. PubMed ID: 28683325
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5).
Haas LT; Kostylev MA; Strittmatter SM
J Biol Chem; 2014 Oct; 289(41):28460-77. PubMed ID: 25148681
[TBL] [Abstract][Full Text] [Related]
3. Oligomers of Amyloid β Prevent Physiological Activation of the Cellular Prion Protein-Metabotropic Glutamate Receptor 5 Complex by Glutamate in Alzheimer Disease.
Haas LT; Strittmatter SM
J Biol Chem; 2016 Aug; 291(33):17112-21. PubMed ID: 27325698
[TBL] [Abstract][Full Text] [Related]
4. Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer's disease.
Haas LT; Salazar SV; Kostylev MA; Um JW; Kaufman AC; Strittmatter SM
Brain; 2016 Feb; 139(Pt 2):526-46. PubMed ID: 26667279
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.
Beraldo FH; Ostapchenko VG; Caetano FA; Guimaraes AL; Ferretti GD; Daude N; Bertram L; Nogueira KO; Silva JL; Westaway D; Cashman NR; Martins VR; Prado VF; Prado MA
J Biol Chem; 2016 Oct; 291(42):21945-21955. PubMed ID: 27563063
[TBL] [Abstract][Full Text] [Related]
6. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein.
Um JW; Kaufman AC; Kostylev M; Heiss JK; Stagi M; Takahashi H; Kerrisk ME; Vortmeyer A; Wisniewski T; Koleske AJ; Gunther EC; Nygaard HB; Strittmatter SM
Neuron; 2013 Sep; 79(5):887-902. PubMed ID: 24012003
[TBL] [Abstract][Full Text] [Related]
7. Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease.
Abd-Elrahman KS; Ferguson SSG
Annu Rev Pharmacol Toxicol; 2022 Jan; 62():235-254. PubMed ID: 34516293
[TBL] [Abstract][Full Text] [Related]
8. A positive allosteric modulator of mGluR5 promotes neuroprotective effects in mouse models of Alzheimer's disease.
Bellozi PMQ; Gomes GF; da Silva MCM; Lima IVA; Batista CRÁ; Carneiro Junior WO; Dória JG; Vieira ÉLM; Vieira RP; de Freitas RP; Ferreira CN; Candelario-Jalil E; Wyss-Coray T; Ribeiro FM; de Oliveira ACP
Neuropharmacology; 2019 Dec; 160():107785. PubMed ID: 31541651
[TBL] [Abstract][Full Text] [Related]
9. Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer's disease mouse models.
Abd-Elrahman KS; Hamilton A; Vasefi M; Ferguson SSG
Mol Brain; 2018 Apr; 11(1):19. PubMed ID: 29631635
[TBL] [Abstract][Full Text] [Related]
10. Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q.
Spurrier J; Nicholson L; Fang XT; Stoner AJ; Toyonaga T; Holden D; Siegert TR; Laird W; Allnutt MA; Chiasseu M; Brody AH; Takahashi H; Nies SH; Pérez-Cañamás A; Sadasivam P; Lee S; Li S; Zhang L; Huang YH; Carson RE; Cai Z; Strittmatter SM
Sci Transl Med; 2022 Jun; 14(647):eabi8593. PubMed ID: 35648810
[TBL] [Abstract][Full Text] [Related]
11. Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer's disease.
Hamilton A; Esseltine JL; DeVries RA; Cregan SP; Ferguson SS
Mol Brain; 2014 May; 7():40. PubMed ID: 24886239
[TBL] [Abstract][Full Text] [Related]
12. Brain mGluR5 in mice with amyloid beta pathology studied with in vivo [
Fang XT; Eriksson J; Antoni G; Yngve U; Cato L; Lannfelt L; Sehlin D; Syvänen S
Neuropharmacology; 2017 Feb; 113(Pt A):293-300. PubMed ID: 27743932
[TBL] [Abstract][Full Text] [Related]
13. Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5.
Brody AH; Strittmatter SM
Adv Pharmacol; 2018; 82():293-323. PubMed ID: 29413525
[TBL] [Abstract][Full Text] [Related]
14. Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model.
Hamilton A; Vasefi M; Vander Tuin C; McQuaid RJ; Anisman H; Ferguson SS
Cell Rep; 2016 May; 15(9):1859-65. PubMed ID: 27210751
[TBL] [Abstract][Full Text] [Related]
15. Aβ oligomers induce pathophysiological mGluR5 signaling in Alzheimer's disease model mice in a sex-selective manner.
Abd-Elrahman KS; Albaker A; de Souza JM; Ribeiro FM; Schlossmacher MG; Tiberi M; Hamilton A; Ferguson SSG
Sci Signal; 2020 Dec; 13(662):. PubMed ID: 33323410
[TBL] [Abstract][Full Text] [Related]
16. Conditional Deletion of
Salazar SV; Gallardo C; Kaufman AC; Herber CS; Haas LT; Robinson S; Manson JC; Lee MK; Strittmatter SM
J Neurosci; 2017 Sep; 37(38):9207-9221. PubMed ID: 28842420
[TBL] [Abstract][Full Text] [Related]
17. Neuronal Store-Operated Calcium Entry and Mushroom Spine Loss in Amyloid Precursor Protein Knock-In Mouse Model of Alzheimer's Disease.
Zhang H; Wu L; Pchitskaya E; Zakharova O; Saito T; Saido T; Bezprozvanny I
J Neurosci; 2015 Sep; 35(39):13275-86. PubMed ID: 26424877
[TBL] [Abstract][Full Text] [Related]
18. Aβ pathology downregulates brain mGluR5 density in a mouse model of Alzheimer.
Lee M; Lee HJ; Park IS; Park JA; Kwon YJ; Ryu YH; Kim CH; Kang JH; Hyun IY; Lee KC; Choi JY
Neuropharmacology; 2018 May; 133():512-517. PubMed ID: 29427650
[TBL] [Abstract][Full Text] [Related]
19. Negative versus positive allosteric modulation of metabotropic glutamate receptors (mGluR5): indices for potential pro-cognitive drug properties based on EEG network oscillations and sleep-wake organization in rats.
Ahnaou A; Langlois X; Steckler T; Bartolome-Nebreda JM; Drinkenburg WH
Psychopharmacology (Berl); 2015 Mar; 232(6):1107-22. PubMed ID: 25323624
[TBL] [Abstract][Full Text] [Related]
20. Ca(2+)/calmodulin-dependent protein kinase II interacts with group I metabotropic glutamate and facilitates receptor endocytosis and ERK1/2 signaling: role of β-amyloid.
Raka F; Di Sebastiano AR; Kulhawy SC; Ribeiro FM; Godin CM; Caetano FA; Angers S; Ferguson SS
Mol Brain; 2015 Mar; 8():21. PubMed ID: 25885040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
